176 related articles for article (PubMed ID: 18047848)
1. Lipids, lipoproteins, and peroxisome proliferator activated receptor-delta.
Sprecher DL
Am J Cardiol; 2007 Dec; 100(11 A):n20-4. PubMed ID: 18047848
[TBL] [Abstract][Full Text] [Related]
2. Regulatory role of peroxisome proliferator-activated receptor delta (PPAR delta) in muscle metabolism. A new target for metabolic syndrome treatment?
Grimaldi PA
Biochimie; 2005 Jan; 87(1):5-8. PubMed ID: 15733729
[TBL] [Abstract][Full Text] [Related]
3. Roles of peroxisome proliferator-activated receptor delta (PPARdelta) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndrome.
Luquet S; Lopez-Soriano J; Holst D; Gaudel C; Jehl-Pietri C; Fredenrich A; Grimaldi PA
Biochimie; 2004 Nov; 86(11):833-7. PubMed ID: 15589693
[TBL] [Abstract][Full Text] [Related]
4. Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men.
Risérus U; Sprecher D; Johnson T; Olson E; Hirschberg S; Liu A; Fang Z; Hegde P; Richards D; Sarov-Blat L; Strum JC; Basu S; Cheeseman J; Fielding BA; Humphreys SM; Danoff T; Moore NR; Murgatroyd P; O'Rahilly S; Sutton P; Willson T; Hassall D; Frayn KN; Karpe F
Diabetes; 2008 Feb; 57(2):332-9. PubMed ID: 18024853
[TBL] [Abstract][Full Text] [Related]
5. Changes in expression levels of genes involved in fatty acid metabolism: upregulation of all three members of the PPAR family (alpha, gamma, delta) and the newly described adiponectin receptor 2, but not adiponectin receptor 1 during neonatal cardiac development of the rat.
Steinmetz M; Quentin T; Poppe A; Paul T; Jux C
Basic Res Cardiol; 2005 May; 100(3):263-9. PubMed ID: 15754086
[TBL] [Abstract][Full Text] [Related]
6. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
[TBL] [Abstract][Full Text] [Related]
7. Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia? Role of beta2-adrenergic agonists.
Fuster G; Busquets S; Ametller E; Olivan M; Almendro V; de Oliveira CC; Figueras M; López-Soriano FJ; Argilés JM
Cancer Res; 2007 Jul; 67(13):6512-9. PubMed ID: 17616713
[TBL] [Abstract][Full Text] [Related]
8. Selective PPARdelta agonist treatment increases skeletal muscle lipid metabolism without altering mitochondrial energy coupling: an in vivo magnetic resonance spectroscopy study.
Jucker BM; Yang D; Casey WM; Olzinski AR; Williams C; Lenhard SC; Legos JJ; Hawk CT; Sarkar SK; Newsholme SJ
Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1256-64. PubMed ID: 17726146
[TBL] [Abstract][Full Text] [Related]
9. Tetradecylthioacetic acid attenuates dyslipidaemia in male patients with type 2 diabetes mellitus, possibly by dual PPAR-alpha/delta activation and increased mitochondrial fatty acid oxidation.
Løvås K; Røst TH; Skorve J; Ulvik RJ; Gudbrandsen OA; Bohov P; Wensaas AJ; Rustan AC; Berge RK; Husebye ES
Diabetes Obes Metab; 2009 Apr; 11(4):304-14. PubMed ID: 19267708
[TBL] [Abstract][Full Text] [Related]
10. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy.
Cheng L; Ding G; Qin Q; Huang Y; Lewis W; He N; Evans RM; Schneider MD; Brako FA; Xiao Y; Chen YE; Yang Q
Nat Med; 2004 Nov; 10(11):1245-50. PubMed ID: 15475963
[TBL] [Abstract][Full Text] [Related]
11. Regulation of skeletal muscle physiology and metabolism by peroxisome proliferator-activated receptor delta.
Ehrenborg E; Krook A
Pharmacol Rev; 2009 Sep; 61(3):373-93. PubMed ID: 19805479
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-delta agonist enhances vasculogenesis by regulating endothelial progenitor cells through genomic and nongenomic activations of the phosphatidylinositol 3-kinase/Akt pathway.
Han JK; Lee HS; Yang HM; Hur J; Jun SI; Kim JY; Cho CH; Koh GY; Peters JM; Park KW; Cho HJ; Lee HY; Kang HJ; Oh BH; Park YB; Kim HS
Circulation; 2008 Sep; 118(10):1021-33. PubMed ID: 18711014
[TBL] [Abstract][Full Text] [Related]
13. Role of peroxisome proliferator-activated receptor beta/delta in chicken adipogenesis.
Sato K; Yonemura T; Ishii H; Toyomizu M; Kamada T; Akiba Y
Comp Biochem Physiol A Mol Integr Physiol; 2009 Nov; 154(3):370-5. PubMed ID: 19619666
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice.
Chen W; Wang LL; Liu HY; Long L; Li S
Basic Clin Pharmacol Toxicol; 2008 Sep; 103(3):240-6. PubMed ID: 18684227
[TBL] [Abstract][Full Text] [Related]
15. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
Rieck M; Meissner W; Ries S; Müller-Brüsselbach S; Müller R
Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617
[TBL] [Abstract][Full Text] [Related]
16. Triglyceride:high-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor delta agonist.
Sprecher DL; Massien C; Pearce G; Billin AN; Perlstein I; Willson TM; Hassall DG; Ancellin N; Patterson SD; Lobe DC; Johnson TG
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):359-65. PubMed ID: 17110604
[TBL] [Abstract][Full Text] [Related]
17. Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist.
Chen X; Matthews J; Zhou L; Pelton P; Liang Y; Xu J; Yang M; Cryan E; Rybczynski P; Demarest K
Metabolism; 2008 Nov; 57(11):1516-25. PubMed ID: 18940388
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta.
Muoio DM; MacLean PS; Lang DB; Li S; Houmard JA; Way JM; Winegar DA; Corton JC; Dohm GL; Kraus WE
J Biol Chem; 2002 Jul; 277(29):26089-97. PubMed ID: 12118038
[TBL] [Abstract][Full Text] [Related]
19. PPARdelta agonism induces a change in fuel metabolism and activation of an atrophy programme, but does not impair mitochondrial function in rat skeletal muscle.
Constantin D; Constantin-Teodosiu D; Layfield R; Tsintzas K; Bennett AJ; Greenhaff PL
J Physiol; 2007 Aug; 583(Pt 1):381-90. PubMed ID: 17540700
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.
Pellieux C; Montessuit C; Papageorgiou I; Lerch R
Cardiovasc Res; 2009 May; 82(2):341-50. PubMed ID: 19131364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
